Pfizer must pay $142 million for the marketing and prescribing of epilepsy drug Neurontin for unapproved uses, a federal appeals court has ruled. The justices refused to overturn a jury’s previous...
EarlySense releases new monitoring system
Apr 17, 2013
EarlySense recently introduced a new patient monitoring system for providers. The EarlySense System monitors heart rate and respiration.
Detection system helps prevent development of pressure sores
Jun 29, 2011
EarlySense Ltd. has received federal clearance for its EverOn Touch system. The product provides continuous resident monitoring. Online alerts let staff know when a resident has moved. This helps staff...